BCHE and Alzheimer disease: The multidisciplinary based approach plays a substantial role in the discovery of new drug candidates, for example, galanthamine is one most prevalent cholinesterase inhibitors that are being used clinically in the symptomatic relief of Alzheimer’s disease (Marucci et al., 2021).